Human Induced Pluripotent Stem Cells: The Past, Present, and Future
被引:24
|
作者:
Hussein, S. M. I.
论文数: 0引用数: 0
h-index: 0
机构:
Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, CanadaMt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
Hussein, S. M. I.
[1
]
Nagy, K.
论文数: 0引用数: 0
h-index: 0
机构:
Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, CanadaMt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
Nagy, K.
[1
]
Nagy, A.
论文数: 0引用数: 0
h-index: 0
机构:
Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
Univ Toronto, Dept Mol Genet, Toronto, ON, CanadaMt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
Nagy, A.
[1
,2
]
机构:
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
HUMAN SOMATIC-CELLS;
HUMAN FIBROBLASTS;
INDUCTION;
GENERATION;
VECTOR;
DIFFERENTIATION;
EXCISION;
VIRUS;
D O I:
10.1038/clpt.2011.37
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
A major breakthrough in the past 5 years is the development of the ability to reprogram somatic cells to pluripotency. It has rejuvenated the field of stem cell research, providing regenerative medicine with new possibilities. In this paper, we discuss the progress made in the reprogramming field with focus on induction methodologies, the use of induced pluripotent stem cells (iPSCs) for drug discovery, and issues and precautions related to their use in regenerative medicine.
机构:
Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl, New York, NY 10029 USAIcahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl, New York, NY 10029 USA
机构:
Department of Animal Science, University of Connecticut/UCONN Stem Cell InstituteDepartment of Animal Science, University of Connecticut/UCONN Stem Cell Institute